Home > Balance Sheet > MARKSANS PHARMA

MARKSANS PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹3.66 Cr₹11 Cr₹15 Cr₹14 Cr₹7.26 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of MARKSANS PHARMA is ₹3.66 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹3.66 Cr
Mar2024₹11 Cr
Mar2023₹15 Cr
Mar2022₹14 Cr
Mar2021₹7.26 Cr

How is Deferred Tax Assets / Liabilities of MARKSANS PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹3.66 Cr
-65.52
Mar2024 ₹11 Cr
-30.98
Mar2023 ₹15 Cr
11.78
Mar2022 ₹14 Cr
89.48
Mar2021 ₹7.26 Cr -

Compare Deferred Tax Assets / Liabilities of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹7,298.8 Cr -4.7% -11.5% -37.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹393,323.0 Cr 1.7% -5.7% -7.4% Stock Analytics
DIVIS LABORATORIES ₹160,825.0 Cr 0.8% -6.7% 3.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,349.0 Cr 0.6% 4.3% 24.4% Stock Analytics
CIPLA ₹106,048.0 Cr -4.7% -12.3% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,494.0 Cr 6.3% -2.1% -4.1% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-4.7%

-11.5%

-37.1%

SENSEX

-1.7%

-4.3%

6.2%


You may also like the below Video Courses